Augmentation of Meniscal Repair With Marrow Stimulation Techniques (Microfractures) (men_micro)

June 10, 2018 updated by: Rafał Kamiński, Centre of Postgraduate Medical Education

Augmentation of Meniscal Repair With Bone Marrow Stimulation Techniques (Microfractures): a Double Blind, Prospective, Randomized Clinical Trial of Efficacy and Safety.

This study will compare meniscal healing augmented or without augmentation with bone marrow stimulation techniques The assessments will include validated, disease specific, patient oriented outcome measures, second look arthroscopy during second step ACL reconstruction. Results of this study will help ascertain whether microfractures improve meniscal healing rates.

Study Overview

Detailed Description

The role of meniscal in the knee integrity is pivotal and lack or partial role of the meniscus increases rate of joint degeneration. Partial meniscal removal is the most popular procedure and meniscal repair remain in minority of arthroscopic surgeries. As criteria of inclusion to meniscal repair are very rough, still success rates of meniscal repair remain in the 60-80% range for isolated repairs. This rate is greater when performed with ACL reconstruction. We believe that augmentation with bone marrow stimulation techniques will induce more complete and possibly faster healing.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Woj. Mazowieckie
      • Otwock, Woj. Mazowieckie, Poland, 05-400
        • Prof. A. Gruca Teaching Hospital, The Medical Centre of Postgraduate Education

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Complete vertical longitudinal tear > 10 mm in length
  • Tear located in the vascular portion of the meniscus, only in red-white zone
  • Unstable peripheral tear
  • Single tear of the medial and/or lateral meniscus
  • Meniscal injury 1 -18 month prior surgery
  • Planned second step arthroscopy (ACL reconstruction)
  • Skeletally mature patients 18-55 years of age

Exclusion Criteria:

  • discoid meniscus
  • arthritic changes (Kellgren Lawrence scale >2)
  • non repairable meniscus
  • degenerative or presence of crystals in meniscus
  • concomitant procedure (acl reconstruction, microfracturing, trephination)
  • inflammatory diseases (i.e. rheumatoid arthritis)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: with microfractures
Standardized meniscal repair with bone marrow stimulation techniques (microfractures)
following meniscal repair, microfractures will be created on the intercondylar and outer part of femoral condyle (outside of joint surface), lateral or medial, respectively
Placebo Comparator: without microfractures
Standardized meniscal repair without augmentation
standard procedure meniscal repair without augmentation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Second look arthroscopy (assessment of meniscal healing integrity during second look)
Time Frame: 8-18 weeks
The primary outcome measures will be assessment of meniscal healing integrity during second look arthroscopy 3-5 months post repair.
8-18 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale
Time Frame: 6 weeks, 12 weeks, 6mts, 1yr post op, 2yrs post op, 3 yrs post op
Pain Visual Analog Scale.
6 weeks, 12 weeks, 6mts, 1yr post op, 2yrs post op, 3 yrs post op
Knee injury and Osteoarthritis Outcome Score scale
Time Frame: 6 weeks, 12 weeks, 6mts, 1yr post op, 2yrs post op, 3 yrs post op
Knee injury and Osteoarthritis Outcome Score
6 weeks, 12 weeks, 6mts, 1yr post op, 2yrs post op, 3 yrs post op
International Knee Documentation Committee - Subjective Knee Evaluation Form
Time Frame: 6 weeks, 12 weeks, 6mts, 1yr post op, 2yrs post op, 3 yrs post op
International Knee Documentation Committee - Subjective Knee Evaluation Form
6 weeks, 12 weeks, 6mts, 1yr post op, 2yrs post op, 3 yrs post op
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: 6 weeks, 12 weeks, 6mts, 1yr post op, 2yrs post op, 3 yrs post op
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
6 weeks, 12 weeks, 6mts, 1yr post op, 2yrs post op, 3 yrs post op

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rafał Kamiński, M.D. Ph.D., SPSK Prof A. Gruca Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 19, 2013

Primary Completion (Actual)

February 1, 2016

Study Completion (Actual)

April 1, 2018

Study Registration Dates

First Submitted

December 17, 2014

First Submitted That Met QC Criteria

December 22, 2014

First Posted (Estimate)

December 23, 2014

Study Record Updates

Last Update Posted (Actual)

June 12, 2018

Last Update Submitted That Met QC Criteria

June 10, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • men_micro

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Meniscus Lesion

Clinical Trials on with microfractures

3
Subscribe